Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,080 | -25,540 | -12,711 | -936 | -42,694 |
| Depreciation Amortization | 538 | 272 | 161 | 67 | 229 |
| Accounts receivable | N/A | N/A | N/A | -11,500 | N/A |
| Accounts payable and accrued liabilities | 497 | 522 | 435 | 525 | -838 |
| Other Working Capital | -535 | 557 | 309 | -11,698 | 1,635 |
| Other Operating Activity | 6,998 | 5,305 | 3,520 | 12,757 | 11,461 |
| Operating Cash Flow | $-27,582 | $-18,884 | $-8,286 | $-10,785 | $-30,207 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 69,000 | 54,800 | 35,600 | 20,500 | 69,849 |
| PPE Investments | -1,084 | -723 | -684 | -380 | -1,691 |
| Purchase Of Investment | -68,914 | -59,086 | -46,216 | -9,285 | -71,738 |
| Investing Cash Flow | $-998 | $-5,009 | $-11,300 | $10,835 | $-3,580 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,975 | 4,975 | 4,975 | 4,975 | 34,460 |
| Debt Repayment | -5 | -3 | -1 | 0 | N/A |
| Common Stock Issued | 28,676 | 28,677 | 28,632 | 28,390 | 453 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 319 |
| Financing Cash Flow | $33,646 | $33,649 | $33,606 | $33,365 | $35,232 |
| Beginning Cash Position | 10,686 | 10,686 | 10,686 | 10,686 | 9,241 |
| End Cash Position | 15,752 | 20,442 | 24,706 | 44,101 | 10,686 |
| Net Cash Flow | $5,066 | $9,756 | $14,020 | $33,415 | $1,445 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,582 | -18,884 | -8,286 | -10,785 | -30,207 |
| Capital Expenditure | -1,084 | -723 | -684 | -380 | -1,691 |
| Free Cash Flow | -28,666 | -19,607 | -8,970 | -11,165 | -31,898 |